Literature DB >> 29131440

miR-193b availability is antagonized by LncRNA-SNHG7 for FAIM2-induced tumour progression in non-small cell lung cancer.

Kelin She1,2, Hui Yan3, Jun Huang4,5,6, Huaping Zhou1, Jianxing He1,4,5,6.   

Abstract

OBJECTIVES: Long non-coding RNAs have identified to involve into the tumour cell proliferation, apoptosis and metastasis. We previously found that up-regulated LncRNA-SNHG7 (SNHG7) positively correlated to the Fas apoptosis inhibitory molecule 2 (FAIM2) in lung cancer cells with unclear mechanism.
METHODS: Non-small cell lung cancer (NSCLC) and relative normal tissues (n = 25) were collected. The SNHG7 expression and function in NSCLC was determined. The SNHG7-miR 193b-FAIM2 network was analysed in vitro and vivo.
RESULTS: We reported that oncogene SNHG7 predicted a poor clinical outcome and functioned as competitive endogenous RNA (ceRNA) antagonized microRNA-193b (miR-193b) to up-regulate the FAIM2 level in NSCLC. Bioinformatic analysis predicted that SNHG7 harboured miR-193b-binding sites, and we found decreased miR-193b levels in NSCLC tissues when compared to relative normal tissues. Luciferase assays indicated that overexpression of miR-193b inhibited the Ruc expression of plasmid with miR-193b-binding sites of SNHG7 in a dose-dependent manner. Ectopically expressed SNHG7 also as a molecular sponge sequestered endogenous miR-193b. Besides, FAIM2 was found to be directly targeted by miR-193b. The restoration of miR-193b levels in NSCLC cell lines A549 and H125 suppressed the expression of FAIM2 and related tumour proliferation, metastasis and induced apoptosis. However, forced expression of SNHG7 could down-regulate miR-193b to elevate the FAIM2 level of tumour cells, leading to impaired miR-193b/FAIM2-induced tumour progression. Knockdown of SNHG7 in vivo significantly delayed the tumour growth with decreased tumour volume, which accompanied with enhanced miR-193b expression and reduced FAIM2 levels.
CONCLUSION: The results indicated that miR-193b is indispensible for the ceRNA role of SNHG7 in FAIM2-supported tumourigenesis of lung cancer.
© 2017 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29131440      PMCID: PMC6528931          DOI: 10.1111/cpr.12406

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  29 in total

Review 1.  MicroRNAs in cancer: biomarkers, functions and therapy.

Authors:  Josie Hayes; Pier Paolo Peruzzi; Sean Lawler
Journal:  Trends Mol Med       Date:  2014-07-12       Impact factor: 11.951

2.  miR-193b availability is antagonized by LncRNA-SNHG7 for FAIM2-induced tumour progression in non-small cell lung cancer.

Authors:  Kelin She; Hui Yan; Jun Huang; Huaping Zhou; Jianxing He
Journal:  Cell Prolif       Date:  2017-11-12       Impact factor: 6.831

Review 3.  The evolving locally-advanced non-small cell lung cancer landscape: Building on past evidence and experience.

Authors:  Benoite Méry; Jean-Baptiste Guy; Aurélie Swalduz; Alexis Vallard; Cyril Guibert; Hweej Almokhles; Majed Ben Mrad; Romain Rivoirard; Alexander T Falk; Pierre Fournel; Nicolas Magné
Journal:  Crit Rev Oncol Hematol       Date:  2015-06-07       Impact factor: 6.312

Review 4.  Chemoradiotherapy of locally advanced nonsmall cell lung cancer: state of the art and perspectives.

Authors:  Delphine Antoni; Françoise Mornex
Journal:  Curr Opin Oncol       Date:  2016-03       Impact factor: 3.645

5.  The imprinted H19 lncRNA antagonizes let-7 microRNAs.

Authors:  Amanda N Kallen; Xiao-Bo Zhou; Jie Xu; Chong Qiao; Jing Ma; Lei Yan; Lingeng Lu; Chaochun Liu; Jae-Sung Yi; Haifeng Zhang; Wang Min; Anton M Bennett; Richard I Gregory; Ye Ding; Yingqun Huang
Journal:  Mol Cell       Date:  2013-09-19       Impact factor: 17.970

Review 6.  Non-Coding RNAs Including miRNAs and lncRNAs in Cardiovascular Biology and Disease.

Authors:  Masaharu Kataoka; Da-Zhi Wang
Journal:  Cells       Date:  2014-08-22       Impact factor: 6.600

7.  The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling.

Authors:  Peng Han; Jing-Wen Li; Bo-Miao Zhang; Jia-Chen Lv; Yong-Min Li; Xin-Yue Gu; Zhi-Wei Yu; Yun-He Jia; Xue-Feng Bai; Li Li; Yan-Long Liu; Bin-Bin Cui
Journal:  Mol Cancer       Date:  2017-01-13       Impact factor: 27.401

8.  LncRNA loc285194 is a p53-regulated tumor suppressor.

Authors:  Qian Liu; Jianguo Huang; Nanjiang Zhou; Ziqiang Zhang; Ali Zhang; Zhaohui Lu; Fangting Wu; Yin-Yuan Mo
Journal:  Nucleic Acids Res       Date:  2013-04-04       Impact factor: 16.971

9.  A combinatorial microRNA therapeutics approach to suppressing non-small cell lung cancer.

Authors:  A L Kasinski; K Kelnar; C Stahlhut; E Orellana; J Zhao; E Shimer; S Dysart; X Chen; A G Bader; F J Slack
Journal:  Oncogene       Date:  2014-09-01       Impact factor: 9.867

10.  FAIM2, as a novel diagnostic maker and a potential therapeutic target for small-cell lung cancer and atypical carcinoid.

Authors:  Hio Chung Kang; Jong In Kim; Hee Kyung Chang; Gavitt Woodard; Young Sik Choi; Ja-Lok Ku; David M Jablons; Il-Jin Kim
Journal:  Sci Rep       Date:  2016-09-28       Impact factor: 4.379

View more
  62 in total

1.  miR-193b availability is antagonized by LncRNA-SNHG7 for FAIM2-induced tumour progression in non-small cell lung cancer.

Authors:  Kelin She; Hui Yan; Jun Huang; Huaping Zhou; Jianxing He
Journal:  Cell Prolif       Date:  2017-11-12       Impact factor: 6.831

2.  Fabrication of magnetic nanochains linked with CTX and curcumin for dual modal imaging detection and limitation of early tumour.

Authors:  Yuedi Yang; Zhongbing Huang; Ximing Pu; Guangfu Yin; Lei Wang; Fabao Gao
Journal:  Cell Prolif       Date:  2018-08-21       Impact factor: 6.831

3.  NFKB1-miR-612-FAIM2 pathway regulates tumorigenesis in neurofibromatosis type 1.

Authors:  Meng Wang; Zengtao Wang; Xiaolei Zhu; Shibing Guan; Zhibo Liu
Journal:  In Vitro Cell Dev Biol Anim       Date:  2019-06-13       Impact factor: 2.416

4.  miR-140-3p inhibits progression of non-small cell lung cancer by targeting Janus kinase 1.

Authors:  Chuan Hu; Yong Zou; Luan-Lian Jing
Journal:  J Biosci       Date:  2020       Impact factor: 1.826

5.  LINC00994 promoted invasion and proliferation of gastric cancer cell via regulating miR-765-3p.

Authors:  Ling Yuan; Tingting Ma; Wenjing Liu; Yan Chen; Qihui Yuan; Mengyi Ye; Lei Yu; Jiaxin Li; Yang Niu; Yi Nan
Journal:  Am J Transl Res       Date:  2019-10-15       Impact factor: 4.060

6.  miR-137 suppresses cell growth and extracellular matrixdegradation through regulating ADAMTS-5 in chondrocytes.

Authors:  Yuanmin Zhang; Guodong Wang; Longfei Ma; Chengqun Wang; Lina Wang; Yanxia Guo; Xiaowei Zhao
Journal:  Am J Transl Res       Date:  2019-11-15       Impact factor: 4.060

7.  CircRNA hsa_circ_100395 regulates miR-1228/TCF21 pathway to inhibit lung cancer progression.

Authors:  Daishi Chen; Wei Ma; Zhaoyang Ke; Fei Xie
Journal:  Cell Cycle       Date:  2018-09-13       Impact factor: 4.534

8.  LncARSR promotes non-small-cell lung cancer progression via regulating PTEN/Akt.

Authors:  Jie Ying; Jian Yang; Yingzi Liu
Journal:  Am J Transl Res       Date:  2020-03-15       Impact factor: 4.060

9.  lncRNA RPSAP52 induced the development of tongue squamous cell carcinomas via miR-423-5p/MYBL2.

Authors:  Xiaozhen Wu; Zuode Gong; Long Ma; Qibao Wang
Journal:  J Cell Mol Med       Date:  2021-03-30       Impact factor: 5.310

10.  LncRNA BCRT1 facilitates osteosarcoma progression via regulating miR-1303/FGF7 axis.

Authors:  Gang Han; Quanyi Guo; Ning Ma; Wenzhi Bi; Meng Xu; Jinpeng Jia; Wei Wang
Journal:  Aging (Albany NY)       Date:  2021-06-08       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.